2013
Impact of HIV drug resistance on virologic and immunologic failure and mortality in a cohort of patients on antiretroviral therapy in China
Liao L, Xing H, Su B, Wang Z, Ruan Y, Wang X, Liu Z, Lu Y, Yang S, Zhao Q, Vermund SH, Chen RY, Shao Y. Impact of HIV drug resistance on virologic and immunologic failure and mortality in a cohort of patients on antiretroviral therapy in China. AIDS 2013, 27: 1815-1824. PMID: 23803794, PMCID: PMC3694318, DOI: 10.1097/qad.0b013e3283611931.Peer-Reviewed Original ResearchConceptsCombination antiretroviral therapyHIV drug resistanceImmunologic failureHigh mortalityVirologic failureAntiretroviral therapyEmergence of HIVDRBaseline CD4 cell countDrug resistanceCD4 cell countCohort of patientsSecond-line drugsEnd of studyProportional hazards modelRural Chinese countiesHIVDR mutationsMedian timePatient adherenceKaplan-MeierChinese patientsRisk factorsHazards modelPatientsCell countMortality
2012
Treatment outcomes of pediatric oncology patients in Zambia.
Slone J, Chunda-Liyoka C, Perez M, Mutalima N, Newton R, Chintu C, Kankasa C, Chipeta J, Heimburger D, Vermund S, Friedman D. Treatment outcomes of pediatric oncology patients in Zambia. Journal Of Clinical Oncology 2012, 30: 9558-9558. DOI: 10.1200/jco.2012.30.15_suppl.9558.Peer-Reviewed Original ResearchUniversity Teaching HospitalAbandonment of treatmentPediatric oncology careLow-middle income countriesOncology careCohort of patientsMajority of patientsMedical record reviewPalliative regimensCommon diagnosisRecord reviewDecreased riskRetrospective studyTreatment abandonmentHistopathological diagnosisRisk factorsKaposi's sarcomaTeaching hospitalTreatment outcomesInclusion criteriaAverage ageDiagnosisCohortWilms tumorCommon outcome